Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis by Eric N. Ouattara (6890174)

“…Outcomes from the model included life expectancy, 10-year medical resource use, incremental cost-effectiveness ratios (ICERs) in $/year of life saved (YLS), and 5-year budget impact. We simulated people with HIV (PWH) in care (mean CD4: 259/<i>μ</i>L, SD 198/<i>μ</i>L) and transmitted cases. …”

FGF18 injections increase TIMP1 and decrease MMP13 and NOGGIN, suggesting healing of degeneration induction of anabolic effect. by Flavia Gomes Velasque Gama (21175112)

Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs. by Jingping Ge (636557)

“…The nuclear p-SMAD2 decreased in <i>RPL5</i> mutant and corrected lines. …”

RJ and pRJ on the PTH-induced decrease in calcium content in the femoral-diaphyseal or femoral-metaphyseal tissues of the rat obtained from normal rats by Saburo Hidaka (18222)

Sign-tracking (ST)–Goal-tracking (GT) score for day 5. by Silvia Fuentes (4759686)

Annual mean energy for the individual wavelet components (thick coloured curves) and a linear model best-fit based on the annual global mean temperature (dashed lines), also estima... by Rasmus E. Benestad (12530330)

Laser scanning confocal microscopy images (a) and quantification (b) of the relative levels of 5-methylcytosine (5mc) and 5-hydroxymethylcytosine (5hmc) in early embryos at the pro... by Shuang Liang (211832)

Foxo1 decreases <i>SCN5a</i> promoter activity. by Weike Mao (181121)

A decrease in circulating CXCR5+CD4+ Tfh cells is associated with HCC progression, and CXCR5+CD4+ Tfh cells are decreased in tumor regions. by Yiqiong Jia (692871)

“…<p>(A) The prevalence of CXCR5+CD4+ Tfh cells decreases with progressive stages in HCC. …”

AQP2 and p-AQP2 abundance. by Sophie Constantin Lütken (689916)

Subjects:

Incubation of <i>T</i>. <i>brucei</i> with Pol I transcription inhibitors results in a dramatic decrease in VEX1 foci. by Louise E. Kerry (3815164)

AQP1 abundance. by Sophie Constantin Lütken (689916)

Subjects:

AQP4 abundance. by Sophie Constantin Lütken (689916)

Subjects:

(Pro)renin receptor abundance. by Sophie Constantin Lütken (689916)

Subjects:

Type 1_A angiotensin II receptor abundance. by Sophie Constantin Lütken (689916)

Subjects:

Gsα subunit abundance. by Sophie Constantin Lütken (689916)

Subjects:

D-4F and L-5F attenuate hepatic triglyceride accumulation. by Kristine C. McGrath (8269155)

Opinion distributions and mean shadow ban strength versus time under shadow banning control policies for different objective functions on a path network. by Yen-Shao Chen (18264587)

CPZ decreases K⁺-dependent Na⁺, K⁺-ATPase transport activity. by Yasser A. Mahmmoud (562155)

Increased expression of Fz5 receptor matched with a decrease in NeuN immunoreactivity at 16w. by Carlos González-Fernández (2794207)